Preparation of enantiopure methionine, arginine, tryptophan, and proline benzyl esters in…
CD3OD) δ 1.53-1.81 (m, 4H), 2.35 (s, 3H), 3.13 (t,
J=6.4 Hz, 2H), 3.49 (t, J=5.8 Hz, 1H), 5.14 (d, J=12.2 Hz,
1H), 5.19 (d, J=12.2 Hz, 1H) 7.22 (d, J=8.2 Hz, 2H), 7.31-
7.42 (m, 5H), 7.70 (d, J=8.2 Hz, 2H); 13C NMR (75 MHz,
CDCl3) δ 175.33, 157.25, 141.55, 140.48, 135.60, 128.97,
128.56, 128.30, 128.15, 125.68, 66.68, 53.79, 40.85, 30.57,
19.95, 13.58. HRMS (ESI) m/z calcd for C12H18NO2S+
(MH+) 240.10527, found 240.10531.
Compliance with ethical standards
Conflict of interest The authors declare that they have no confict of
interest.
+
25.01, 21.25. HRMS (ESI) m/z calcd for C13H21N4O2
(MH+) 265.16590, found 265.16592. The (R)-Mosher car-
boxylates were prepared by adding an equimolar amount
of (R)-α-methoxy-α-trifluoromethylphenylacetic acid to
a methanolic solution of l-arginine benzyl ester mono-p-
toluenesulfonate (3) or of rac-arginine benzyl ester mono-p-
toluenesulfonate and evaporating the solvent under vacuum.
lR-Salt 1H NMR (600 MHz, CD3OD) δ 1.51-1.80 (m, 2H),
1.83-2.07 (m, 2H), 2.39 (s, 3H), 3.16 (m, 2H), 3.56 (s, 3H),
4.00 (t, J=6.4 Hz, 1H), 5.27 (d, J=12.0 Hz, 1H), 5.31 (d,
J = 12.0 Hz, 1H), 7.26 (d, J = 8.2 Hz, 2H), 7.29-7.46 (m,
8H), 7.66 (m, 2H), 7.72 (d, J=8.2 Hz, 2H). lR/dR-Salt: 1H
NMR (600 MHz, CD3OD) δ 1.52–1.82 (m, 2H), 1.83–2.07
(m, 2H), 2.39 (s, 3H), 3.16 (dt, J=6.4, 2.0 Hz, 2H), 3.56 (s,
3H), 4.00 (t, J = 6.4 Hz, 0.5H), 4.07 (t, J = 6.4 Hz, 0.5H),
5.27 (d, J = 12.0 Hz, 1H), 5.31 (d, J = 12.0 Hz, 1H), 7.26
(d, J=8.2 Hz, 2H), 7.29–7.46 (m, 8H), 7.66 (m, 2H), 7.72
(d, J = 8.2 Hz, 2H). lR-Salt 13C NMR (75 MHz, CD3OD)
δ 170.61, 169.02, 157.29, 141.90, 140.56, 135.75, 135.01,
128.58, 128.40, 128.36, 128.26, 127.49, 125.55, 124.87 (q,
J=288.0 Hz), 85.30 (q, J=24.8 Hz), 67.75, 54.07, 52.17,
40.13, 27.28, 23.92, 19.99; 19F NMR (282 MHz, CD3OD)
δ -67.45.
Ethical approval This article does not contain any studies with human
participants or animals performed by any of the authors.
Informed consent Informed consent was obtained from all individual
participants included in the study.
References
Adams R, Fleš D (1959) The absolute confguration of the C8-atom in
the pyrrolizidine moieties of the Senecio alkaloids. J Am Chem
Soc 81:5803–5805
Arai I, Muramatsu I (1983) A simple and convenient method for
esterifcation of tryptophan and other amino acids. J Org Chem
48:121–123
Aul R, Comanita B (2007) A green alternative to THF. Manuf Chem
78:33–34
Aycock DF (2007) Solvent applications of 2-methyltetrahydrofuran
in organometallic and biphasic reactions. Org Process Res Dev
11:156–159
Azzena U, Carraro M, Pisano L (2015) Un’alternativa “green” al tolu-
ene. La Chimica e l’Industria 97:28–30
Biondini D, Brinchi L, Germani R, Goracci L, Savelli G (2010) Esteri-
fcation of unprotected α-amino acids in ionic liquids as the reac-
tion media. Lett Org Chem 7:39–44
Bolchi C, Pallavicini M, Rusconi C, Diomede L, Ferri N, Corsini A,
Fumagalli L, Pedretti A, Vistoli G, Valoti E (2007) Peptidomi-
metic inhibitors of farnesyltransferase with high in vitro activ-
ity and significant cellular potency. Bioorg Med Chem Lett
17:6192–6196
l‑Methionine benzyl ester p‑toluenesulfonate (4)
Bolchi C, Pallavicini M, Fumagalli L, Ferri N, Corsini A, Rusconi
C, Valoti E (2009) New Ras CAAX mimetics: design, synthesis,
antiproliferative activity, and RAS prenylation inhibition. Bioorg
Med Chem Lett 19:5500–5504
A mixture of l-methionine (0.05 mol), p-toluenesulfonic
acid (0.06 mol), benzyl alcohol (0.50 mol), and Me-THF
(120 mL) was heated at refux with a Dean–Stark trap under
vigorous stirring for 24 h. The reaction mixture was cooled
to rt and the solvent was evaporated under vacuum. The
obtained residue was poured into DCM/aqueous Na2CO3
and, after removing the water layer, the organic phase was
evaporated under vacuum. The residue was diluted with
TAME, cooled to 0 °C, and treated with equimolar p-tol-
uenesulfonic acid to give 4 as a white solid in 62% yield.
M.p. = 129.51 °C, [α]2D5 = + 0.95 (c 1, MeOH); 95.7% e.e.
(determined by HPLC analysis on a Phenomenex Lux
3 μ Amylose-2 column, 150 mm × 4.6 mm i.d.; hexane/
iPrOH 80/20 1 mL/min; 210 nm, tR =11.08 min); 1H NMR
(300 MHz, CDCl3) δ 1.84 (s,3H), 2.10 (m, 2H), 2.30 (s, 3H),
2.43 (m, 2H), 4.14 (m, 1H), 5.00 (d, J=12.3 Hz, 1H), 5.12
(d, J = 12.3 Hz, 1H), 7.08 (d, J = 7.0 Hz, 2H), 7.24–7.30
(m, 5H), 7.73 (d, J=7.0 Hz, 2H), 8.35 (bs, 3H); 13C NMR
(75 MHz, CD3OD) δ 168.76, 142.07, 140.34, 134.96,
128.44, 128.42, 128.32, 125.55, 67.83, 51.49, 29.38, 28.51,
Bolchi C, Valoti E, Fumagalli L, Straniero V, Ruggeri P, Pallavicini M
(2015a) Enantiomerically pure dibenzyl esters of l-aspartic and
l-glutamic acid. Org Process Res Dev 19:878–883
Bolchi C, Valoti E, Gotti C, Fasoli F, Ruggeri P, Fumagalli L, Binda
M, Mucchietto V, Sciaccaluga M, Budriesi R, Fucile S, Pallavicini
M (2015b) Chemistry and pharmacology of a series of unichiral
analogues of 2-(2-pyrrolidinyl)-1,4-benzodioxane, prolinol phenyl
ether, and prolinol 3-pyridyl ether designed as α4β2-nNicotinic
acetylcholine receptor agonists. J Med Chem 58:6665–6677
Bolchi C, Bavo F, Pallavicini M (2017a) One-step preparation of
enantiopure l- or d-amino acid benzyl esters avoiding the use of
banned solvents. Amino Acids 49:965–974
Bolchi C, Bavo F, Pallavicini M (2017b) Phase diagrams to evaluate
the opportunity for enantiomeric enrichment of some nonrace-
mic mixtures of amino acid benzyl esters by crystallization as
p-toluenesulfonate salts. Org Process Res Dev 21:1752–1757
Bräuer TM, Zhang Q, Tiefenbacher K (2016) Iminium catalysis inside
a self-assembled supramolecular capsule: modulation of enantio-
meric excess. Angew Chem Int Ed 55:7698–7701
Byrne FP, Jin S, Paggiola G, Petchey THM, Clark JH, Farmer TJ, Hunt
AJ, McElroy CR, Sherwood J (2016) Tools and techniques for
1 3